18.03.2014 • News

Merck Serono Names Meeta Gulyani to Pharma Executive Committee

Merck Serono, the biopharmaceutical division of Germany's Merck KGaA, has named Meeta Gulyani as head of strategy and global franchises, effective May 7. She will be based in Boston, Massachusetts, U.S. and report to Merck Serono CEO Belén Garijo.

Ms Gulyani will lead Merck Serono's global franchises of multiple sclerosis & immunology, oncology, fertility, general medicine & endocrinology and medical devices, with a strong focus on defining integrated strategies for disease areas.

With this appointment, and the promotion of Elcin Ergun on Jan, 1 as head of commercial, Merck Serono's Pharmaceutical Executive Committee is now complete.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.